SpyGlass Pharma, Inc.
SGP- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001778922
In the last 90 days, SpyGlass Pharma, Inc. insiders filed 1 open-market purchase and 0 sales; 69 institutions reported holding it in 13F filings for Q3 2026, worth $687.8M in total; no superinvestor holds it.
SEC filings
10-K, 10-Q, 8-K, 20-F and 40-F reports SpyGlass Pharma, Inc. filed with the SEC, newest first.
Livermore lists each filing's form, 8-K items and dates only. To read a filing, open it on SEC.gov; an 8-K's press release or other attachments, such as exhibit 99.1 for Item 2.02, are in the filing index.
| Filed | Form | 8-K items | Period | Document | Filing index |
|---|---|---|---|---|---|
| Nov 12, 2026 | 10-Q | – | Sep 30, 2026 | SEC | Index |
| Nov 12, 2026 | 8-K | 2.028.019.01 | Nov 11, 2026 | SEC | Index |
| Oct 19, 2026 | 8-K | 8.019.01 | Oct 19, 2026 | SEC | Index |
| Oct 1, 2026 | 8-K | 7.018.019.01 | Oct 1, 2026 | SEC | Index |
| Aug 6, 2026 | 10-Q | – | Jun 30, 2026 | SEC | Index |
| Aug 6, 2026 | 8-K | 2.029.01 | Aug 6, 2026 | SEC | Index |
| May 14, 2026 | 10-Q | – | Mar 31, 2026 | SEC | Index |
| May 14, 2026 | 8-K | 2.029.01 | May 14, 2026 | SEC | Index |
| Mar 26, 2026 | 10-K | – | Dec 31, 2025 | SEC | Index |
| Mar 26, 2026 | 8-K | 2.029.01 | Mar 26, 2026 | SEC | Index |
| Mar 9, 2026 | 8-K | 8.019.01 | Mar 9, 2026 | SEC | Index |
| Feb 13, 2026 | 8-K | 5.02 | Feb 12, 2026 | SEC | Index |
| Feb 9, 2026 | 8-K | 5.025.037.019.01 | Feb 5, 2026 | SEC | Index |